Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-mesothelin (CRS-207) With or Without Nivolumab in Patients with Pancreatic Cancer

PURPOSE: Two studies in previously-treated metastatic pancreatic cancer have been completed combining GVAX pancreas vaccine (granulocyte-macrophage colony-stimulating factor-secreting allogeneic pancreatic tumor cells) with cyclophosphamide (Cy) and CRS-207 (live, attenuated Listeria monocytogenes e...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Cancer Res
Autors principals: Tsujikawa, Takahiro, Crocenzi, Todd, Durham, Jennifer N., Sugar, Elizabeth, Wu, Annie A., Onners, Beth, Nauroth, Julie M., Anders, Robert A., Fertig, Elana J., Laheru, Daniel A., Reiss, Kim A., Vonderheide, Robert H., Ko, Andrew H., Tempero, Margaret A., Fisher, George A., Considine, Michael, Danilova, Ludmila, Brockstedt, Dirk G., Coussens, Lisa M., Jaffee, Elizabeth M., Le, Dung T.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7727397/
https://ncbi.nlm.nih.gov/pubmed/32273276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3978
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars